MF
FOLD

Magnetar Financial’s Amicus Therapeutics FOLD Stock Holding History

Magnetar Financial’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.6M Buy
3,986,058
+18,143
+0.5% +$260K 0.59% 21
2025
Q4 		$56.5M Buy
+3,967,915
New +$39M 0.55% 23
2025
Q2 		– Sell
-49,393
Closed -$403K – 971
2025
Q1 		$403K Buy
49,393
+29,280
+146% +$271K 0.01% 509
2024
Q4 		$189K Sell
20,113
-1,964
-9% -$20.4K ﹤0.01% 557
2024
Q3 		$236K Buy
+22,077
New +$240K 0.01% 444
2021
Q3 		– Sell
-18,850
Closed -$182 – 1378
2021
Q2 		$182 Sell
18,850
-11,155
-37% -$109K ﹤0.01% 1116
2021
Q1 		$296K Buy
+30,005
New +$464K ﹤0.01% 928

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Magnetar Financial's FOLD Position: Q1 2026 in Review

Magnetar Financial increased its Amicus Therapeutics (FOLD) stake by 0.46% in Q1 2026, buying an estimated $260K and bringing the position to 3,986,058 shares worth $57.6M. The position accounts for 0.59% of the portfolio, ranked #21.

Magnetar Financial first reported a position in FOLD in Q1 2021 and has held it in 7 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Magnetar Financial held 3,986,058 shares of Amicus Therapeutics worth $57.6M as of Q1 2026.
  • Magnetar Financial bought 18,143 Amicus Therapeutics shares in Q1 2026, an estimated $260K.
  • Amicus Therapeutics made up 0.59% of Magnetar Financial's portfolio in Q1 2026, its #21 holding.
  • Magnetar Financial first reported a position in Amicus Therapeutics in Q1 2021 and has held it in 7 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.